Potassium Chloride Injection, Solution, Concentrate
Product Images NDC 63323-967

9 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 63323-967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fklogo (Pot0s 0002 01)

Fklogo (Pot0s 0002 01)
Potassium Chloride 2 meq/mL Injection, Solution, Concentrate packaging label by Fresenius Kabi USA, LLC. The label includes dosage form and strength information, with visible branding for Fresenius Kabi.*
FDA Label Image

5mlvial (Pot0s 0002 02)

5mlvial (Pot0s 0002 02)
Potassium Chloride Injection Concentrate, USP 2 mEq/mL (10 mEq per 5 mL) single dose vial label by Fresenius Kabi USA, LLC. The label indicates the product must be diluted prior to intravenous administration and is preservative free. Additional storage and content information is provided, including dose volume and temperature instructions.*
FDA Label Image

5mltray (Pot0s 0002 03)

5mltray (Pot0s 0002 03)
Potassium Chloride Injection Concentrate USP 2 mEq/mL in a 5 mL vial. The label specifies a concentration of 10 mEq per 5 mL and instructs that the concentrate must be diluted before intravenous administration. Package contains 25 single-dose vials. Preservative-free product by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Potassium Chloride Injection Concentrate, USP labeled as 20 mEq per 10 mL (2 mEq per mL) single-dose vial by Fresenius Kabi USA, LLC. The label highlights that the concentrate must be diluted before use and is preservative free. Storage instructions and contents details are provided alongside a barcode and website URL.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Potassium Chloride Injection Concentrate, USP, 2 mEq/mL (20 mEq per 10 mL) in 25 single-dose 10 mL vials. The label highlights that the concentrate must be diluted prior to intravenous administration. It is preservative-free and sterile, labeled for Rx only, with storage and dosage instructions. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Potassium Chloride Injection Concentrate, USP 2 mEq/mL in a 20 mL single-dose vial. The label highlights that the concentrate must be diluted before use and provides dosing information of 40 mEq per 20 mL. It is preservative-free and labeled by Fresenius Kabi USA, LLC. The packaging includes dosage instructions and storage conditions.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Potassium Chloride Injection Concentrate, USP 40 mEq per 20 mL (2 mEq per mL) in single-dose vials, 25 vials per package. The label highlights that the concentrate must be diluted before intravenous administration. It is preservative-free and sterile, labeled by Fresenius Kabi USA, LLC. The packaging emphasizes storage instructions and warns that vial stoppers do not contain natural rubber latex.*
FDA Label Image

30mlvial (Pot0s 0002 08)

30mlvial (Pot0s 0002 08)
Potassium Chloride Injection Concentrate, USP, 60 mEq per 30 mL (2 mEq per mL) multiple-dose vial label. The label highlights a warning that the concentrate must be diluted before intravenous use. It includes manufacturer Fresenius Kabi USA, LLC and displays NDC 63323-967-01 with storage and dosage instructions.*
FDA Label Image

30mltray (Pot0s 0002 09)

30mltray (Pot0s 0002 09)
Potassium Chloride injection concentrate, USP, 2 mEq/mL, supplied as 25 multiple-dose vials each containing 30 mL. Label states 'Concentrate Must Be Diluted Before Use' and the total strength is 60 mEq per 30 mL. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL, with instructions for intravenous administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.